chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient intentionally and knowingly completed vaccination series of both Moderna and Pfizer COVID-19 vaccines. Upon arrival on 5/7/2021 for his second Moderna dose, patient did not disclose to  nurse that he had received the Pfizer vaccines in between his 1st and 2nd Moderna vaccinations. NJIIS ID 8504524.  Immunization Details Vaccine COVID-19 4/7/2021, COVID-19 2, 4/15/2021, ER8734 , COVID-19, 5/6/2021                                  ER8736, COVID-19, 3, 5/7/2021
I felt fluish first day after last shot and had muscle soreness, but now I am unable to sleep/don't want to sleep. This is very unusual for me. I take medication for depression/anxiety, and trazodone when needed to sleep at night if I'm feeling restless. I've usually had a problem with feeling sleepy during the day. I feel wired for no reason. I don't drink caffeine, I do smoke, but this is like I don't even want to go to sleep. This is not normal for me. Please help.
Body aches, headache, nausea, chills, 100.2 temperature, fatigue
Information has been received from a physician concerning a 2 month old patient with no pertinent medical history or allergies, who on 08 Feb 2007 was vaccinated with Rotateq, "one tube" by mouth (lot # 654663/0942F). There was no concomitant medication. About six hours post vaccination, on 08 Feb 2007, the patient developed projectile vomiting and fits of crying that lasted two days. There were no other symptoms. The baby was on breast milk only. The patient sought unspecified medical attention. On 10 Feb 2007, the patient recovered from projectile vomiting and fits of crying. Additional information has been requested. It was also reported that the patient had no adverse events after two more doses of ROTATEQ. No further information is expected.
In late April, within 3 weeks following HEP-B, pt developed arthralgia and eventually arthritis in his right knee.
Child began itching and scratching her right arm immediately after receiving vaccine. Rash noted on both arms and spread to midchest within 2 minutes. Benadryl .2ml given IM in left thigh. Rash resolved within 5 minutes.
I had the flu shot (for over 65) on Tuesday around noon. Only some localized swelling that afternoon and evening. However, I woke up Wednesday feeling major (!) body-wide pain. All day long every muscle and every joint screamed at me. I was barely able to function. On the Mankowski pain scale of 1-10, I would rate the pain at 7-8, needing oxycodone 10 mg to temporarily relieve the pain. The pain started to subside around 6 pm, and I slept well that evening. On the sheet that was given to me at the time of the injection it listed "muscle or joint pain" as a possible side effect. I would interpret that as possibly being up to a 5 on the pain scale. In my case I would have preferred to have known that SEVERE BODY-WIDE PAIN could be a possible side effect! Luckily I am retired now, because that kind of pain would have precluded being able to function in a job setting.
On the 26th, I started noticing it was hard to close my right eye and when I woke up for work on Saturday the 27th, I realized I was completely numb and after visiting the Emergency Room it was determined that I had developed Bell's Palsy.
She tested positive for COVID-19 on 1/17/22. She had a pretty mild case. She basically had cold symptoms. Her symptoms lasted for about 3 days. The only reason we tested her is because we knew that there was an outbreak at the school.
* Night sweats for several days (very unusual, I am very slim and do not sweat normally at night). * Headache/ general muscle aches/ soreness -not limited to the injection site (like after going on a multiple-day hike) for 3 -4 days. * pain in chest - left side of body, near or affecting the heart. (location is not always specific enough/ or I am unaware of the subtleties/ nuance in that region of my body, as I have never had problems of this nature before) Specific times: Unsure. I have noticed it when I'm doing computer work and when sitting and eating. Duration: not sure when the heart palpitation/ pain/ discomfort started. It was there 3 weeks after and now, 40 days after injection still flares up some days. * Tinnitus, ringing in ears; comes and goes at various times of day. Some days no flare up. Has occurred on day 38 after injection. Very unusual for me. Have not had any specific treatments done for the above two longer-term conditions, other than average holistic care and more attention to sleep patterns.
Approximately 1 week post vax the pt developed chickenpox on the face and trunk with greater than 50 lesions. Pt was treated with Benadryl and Aveeno.
double vision when reading/still seeing double; eyes sensitive to light/eyes still very sensitive to light; burning eyes; unknown spot on left lung, another spot on right lung; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Jun-2021. The most recent information was received on 24-Jul-2021 and was forwarded to Moderna on 24-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (double vision when reading/still seeing double), PHOTOPHOBIA (eyes sensitive to light/eyes still very sensitive to light), EYE IRRITATION (burning eyes) and LUNG DISORDER (unknown spot on left lung, another spot on right lung) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIPLOPIA (double vision when reading/still seeing double), PHOTOPHOBIA (eyes sensitive to light/eyes still very sensitive to light), EYE IRRITATION (burning eyes) and LUNG DISORDER (unknown spot on left lung, another spot on right lung). At the time of the report, DIPLOPIA (double vision when reading/still seeing double) and PHOTOPHOBIA (eyes sensitive to light/eyes still very sensitive to light) had not resolved and EYE IRRITATION (burning eyes) and LUNG DISORDER (unknown spot on left lung, another spot on right lung) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No concomitants were reported. No treatment drugs were reported. On 12-JUL-2021, patient got results of CT scan . It is reported that on an unknown date, patient had high blood sugar lately.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Outcome of the events eyes sensitive to light,blood sugar has been high,double vision when reading were changed from Unknown to Not recovered.Events Burning eyes,Have an Unknown spot on the left lung,another spot on right lung were added.
Severe arm pain as such I could not raise it without help to get dressed. Lots of swelling. Fevers for days.
Approximately 5 minutes after injection, patient developed CP 4/10 no SOB, no diaphoresis.  Patient brought to medical obs tent.  VS 95% O2 Sat RA, HR 80, BP 168/102. Patient has not taken morning medications including for HTN.  Pain decreased to 1/10 with no intervention during assessment.  No numbness, no tingling, no dizziness, no distress.  BP decreased to 148/82.  Patient wishes to follow up with his PCP.  Medical director consulted.  Patient advised to seek 12 lead ECG assessment at local ED or with PCP.  Patient will be going to PCP office at present and will go to local ED if CP returns en route.  No distress noted at time of DC.
CHIEF COMPLAINT:   Per pt, bone marrow transplant in August on 25th. Last night had chills, fever, and diarrhea. Denies COVID exposure, is vaccinated.   HISTORY OF PRESENT ILLNESS:     Patient presenting to the emergency department with diarrhea.  Patient has a history of mild dysplastic syndrome and a bone marrow transplant 4 months ago.  The bone marrow transplant was done at (Privacy).  Began having fevers and chills last night.  Patient arrived in the ED with a temperature of 100.9.  Otherwise feeling well.  Denies any coughing or shortness of breath denies any chest pain.  Nursing note reviewed.
Started having new vitiligo spots up my arm and frequent urination in May of 2021. Ended up in the ICU with Ketoacidosis in August of 2021. My A1C in February of 2020 was a 5.3 and when I was admitted to the hospital with DKA, I was a 13.6
11/1/07 1715 Prob: Fainting episode; Fall trauma 2hours to the above; S: Patient has "needle phobia". Received Gardasil without problems in the left upper arm (deltoid region)....left the room after the mother agreed to watch her. ...went to retrieve the patient's chart and the patient fainted while sitting on exam table. The patient then impacted with the floor injuring her right knee and her left infra orbital cheek bone: using an. ammonia capsule the patient was revived. She was alert and 0 x 3. no seizure  or activity. She was normally reactive when the paramedics arrived. Transported to med ctr's ER to evaluate injury or injuries with a C-collar in place. She was stable on departure no seizures observed, no anaphylactic reaction noted! She was transported in stable and satisfactory condition. 11/12/07 Called to check on progress of patient. She stated her left cheek was perfectly fine, her left knee still hurts and is bruised. I told the patient to notify her mother that I called.
Discharge Provider: DO Primary Care Provider at Discharge: DO  Admission Date: 6/1/2022 Discharge Date: 6/3/2022  PRESENTING PROBLEM: Generalized weakness  AKI (acute kidney injury) (HCC)    HOSPITAL COURSE: 82-year-old female who presents today with hypertension, osteoporosis, chronic pain and cva complaining of weakness for the past 3-4 days. She complains of chronic weakness in in her left leg from prior CVA that has been progressively worse  that is preventing her from transporting to walker or wheeelchair safely, denies falling. She complains of decreased appetite as well. She does state that one of her family members in the home is covid positive. She denies fevers, runny nose or chills but did have 1 episode of emesis today and 2 days of reported mildly productive cough. She decided to to come the emergency room to be evaluated.    Upon arrival to the emergency room she was hypertensive with blood pressure 232/99. Her temperature was 38 degrees celsius. Other vitals were stable. Her blood pressure normalized without intervention. Her covid screen was positive. IV established, basic labs were drawn and sent.  Patient was given Tylenol, Zofran and IV fluids for hydration.  Patient's labs are concerning for mild AKI with a new creatinine of 1.24 slightly elevated from where she has been previously.  Magnesium is low 1.4. She had IV magnesium. Patient has been noted to dip to 88% on her pulse ox in the ER and placed on 2 liters. Chest x-ray does not show any acute disease. Ekg showed Sinus rhythm with 1st degree AV block with occasional premature ventricular complexes . Otherwise normal ECG.Agreeable to admit for observation for acute kidney injury and generalized weakness.    Patient remained stable on room air. Only COVID-19 symptom is an occasional dry cough and generalized fatigue/weakness. AKI improved with gentle IV hydration. Magnesium remained replete, her blood pressure remained controlled. PT/OT evaluated patient and recommended SAR. Patient refusing to go to SAR. Patient and family agree to discharge home with HHC and PT. She was instructed to follow up with her PCP in 5-7 days. She was discharged home with her daughter in a wheelchair. All questions and concerns were addressed prior to discharge.
With the 1st dose I had myalgia, arthralgia and pain at the injection site which began the next morning when I woke up at around 10:00 am and lasted 48 hours.  For the 2nd dose, the reaction was more profound.  I had pain at the injection site within 6 hours of the injection and by the next day around 11:00 am I woke up with myalgia, arthralgia, fever of 101.2 F, fatigue, headache, and sore throat.  Symptoms lasted for 4 days and I missed 2 days of work.
Patient received Pfizer COVID vaccine on 3/16/21 and 4/6/21. On 2/4/22, patient admitted to our inpatient facility (med/surg unit) with acute asthma/COPD exacerbation, acute hypoxic respiratory failure due COVID19 infection, and decompensated alcoholic cirrhosis with ascites. Patient was discharged home in stable condition on 2/7/21.
Information has been received from a consumer concerning her 80 mother with allergies to feathers and codeine and hypertension who on 19-APR-2007 was vaccinated with a dose of Zostavax (Merck). Concomitant therapy included Synthroid and Avapro. On 20-APR-2007 the patient woke in the morning and her face was red and swollen. Medical attention was not sought. There was no product quality complaint involved. Additional information has been requested. 02/10/2010 Follow up information received. Reaction of facial swelling and itching was determined by physician to be related to new prescription medication (per pt). Patient was taken off of medication on 21-Apr-2007 and swelling and itching subsided.
pt recvd vax; next day exp discomfort & soreness of rt leg & devel a fever of 101; redness & swelling at inject site; to md on 17mar95; area still red & sore
Post vax, the medical assistant reported that on 12/12/2000, the patient "broke out with chicken pox". Unspecified medical attention was sought. In follow up the physician reported that the patient recovered. The patient's siblings had a similar experience following exposure to varicella virus vaccine live. No further information is available.
This spontaneous report was received from a health professional refers to an unspecified number of patients of unknown demographics. Pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. On unspecified dates, the patients were administered with doses of VARIVAX (Merck) (Lot # L001335, expiry date: 13-JAN-2017; lot # L001325, expiry date: 13-JAN-2017, lot # L005298, expiry date: 17-FEB-2017) which was exposed to temperatures outside of the recommended range. Concomitant medications were not reported. No adverse experience was reported. This is one of the six reports received from the same source (MARRS # 1506USA014028, 1506USA011037, 1506USA014024, 1506USA014026 and 1506USA014027). Additional information is not expected as the reporter did not wish further contact.
Had shingles vaccine on left arm - 2 days later a lot of redness appeared with bruising - gradually fading as of today 8/7/08.
died from the vaccine; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 4 patients. This is one of four reports. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced died from the vaccine on an unspecified date. The reporter stated in his neighborhood 4 people died from the vaccine. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Follow-up attempts have been completed and no further information is expected. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100970595 same reporter, event and drug, different patient;US-PFIZER INC-202100970596 same reporter/drug/event, different pt;US-PFIZER INC-202100970597 same reporter, event and drug, different patient; Reported Cause(s) of Death: died from the vaccine
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 30-AUG-2016, the patient received a dose of improperly stored ROTATEQ (lot # M019691, expiry date: 02-NOV-2017). Excursion: 1.3C for 77 minutes cumulatively. Data logger was involved. No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Lymphadenopathy; This is a spontaneous report from a contactable healthcare professional who reported for herself, a 40-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: el0142) at the hospital, intramuscular in the left arm on 06Jan2021 at 08:00 at a single dose for COVID-19 immunization. Medical history included "COVID prior vaccination Yes" on an unspecified date. The patient was not pregnant at the time of reporting. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 with lot number: EK7530 at age 40 years, via intramuscular route in the left arm, on 16Dec2020 at 12:00 PM, Nasal Swab test result was positive on 28Dec2020. The patient experienced lymphadenopathy on 07Jan2021 at 19:00. The event was considered as non-serious. No treatment was received for the adverse event. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Caller stated that she had extreme chills, cold sweats, body aches, headaches, and was really weak. Caller stated that she was vomiting every 20 - 30 minutes. The only thing she could keep down was Sprite. Was not able to eat for 2 days.
A little over 2 weeks after receiving my 2nd dose of Pfizer I started out having breathing problems and right leg/ankle swelling.  I would get very winded, especially going up stairs and carrying my granddaughter.  This continue for about 2 months.  Finally on July 9th 2021 when I woke up in the morning I could hardly breathe and ankle/leg were very swollen. My husband took me to the ER.   I was admitted for 6 days with blood clots in my Right Leg and multiple in my Right Lung and a few in my Left Lung.  It will be 3 months and still have some trouble with breathing.  On a blood thinner to try and prevent any farther ones occurring.
The patient's mother contacted pharmacy on 9/23/19 at 1:30pm to report after receiving immunizations on 9/13/19 the patient arrived home about 1 pm and was fine but at about 5pm later the same day the patient began experiencing exasperated symptoms of his M.S. According to mother, patient's neurologist was contacted on Saturday 9/14 and recommended patient proceed to hospital. The patient refused to go to the hospital until Sunday 9/15 when he was transported and hospitalized. The patient was discharged "Wednesday or Thursday" per mother.
A report has been received from a Health Professional concerning a 33 year old, Male subject, who had been receiving Nasal FLUMIST. FLUMIST started on 14-Feb-2013. The patient experienced 103 degrees F temperature, chills, body aches and headache which started on 14-Feb-2013. At the time of reporting, the event of 103 degrees F temperature and chills was improving and at the time of reporting, the event of body aches and headache was ongoing. The report was considered to be non-serious.
Muscle soreness for 2 weeks. Following Flu shot in Left Deltoid the pain has increase as week when on.
I had no side effects other then a little bit of swelling. It lasted for 2 days then it went away. I did get a rash around my chest area. My stomach started swelling in July, I thought I was gaining weight then 30 days later I started having pain and I went to hospital and ended up having an appendicitis .
On approximately 2/25/00, the pt developed chickenpox that consisted of less than twenty lesions. The pt sought unspecified medical attention and was treated with mupriacin, diphenhydramine, calamine, camphor, and pramoxine. Additional information has been requested.
This case was reported by a physician via call center representative and described the occurrence of shingles in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured adult as per vaccine indication. The patient had a mild shingles outbreak before dose two of the SHINGRIX series. This request was coming in through queue. The physician did not specifically mention that the patient did receive the first dose of the SHINGRIX series, but was asking when the second dose could be given after a mild case of shingles. The patient might have the first dose of the series. The physician did not report any patient or vaccine details.
This spontaneous report as received from a consumer refers to her 81 year old female friend. On an unknown date the patient was vaccinated with ZOSTAVAX (lot#, strength, dosage, anatomical location and route unknown). No pertinent medical history was reported. On an unknown date the patient experienced itching after receiving ZOSTAVAX. The patient visited the office on unspecified date. No treatment was given for the event and no lab diagnostics studies was performed. The outcome of itching was not recovered. Additional information has been requested.
crappy feeling; The middle of their body hurts; everything hurt; pain in their chest; pain in their lower abdomen; pain in their chest lower back; middle of their body hurts; had a lot of gas; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (everything hurt), CHEST PAIN (pain in their chest), ABDOMINAL PAIN (pain in their lower abdomen), BACK PAIN (pain in their chest lower back) and DISCOMFORT (middle of their body hurts) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DISCOMFORT (everything hurt), CHEST PAIN (pain in their chest), ABDOMINAL PAIN (pain in their lower abdomen), BACK PAIN (pain in their chest lower back), DISCOMFORT (middle of their body hurts), FLATULENCE (had a lot of gas) and PAIN (The middle of their body hurts). On an unknown date, the patient experienced FEELING ABNORMAL (crappy feeling). The patient was treated with PARACETAMOL (TYLENOL) for Prophylaxis, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Prophylaxis, at an unspecified dose and frequency. At the time of the report, DISCOMFORT (everything hurt), CHEST PAIN (pain in their chest), ABDOMINAL PAIN (pain in their lower abdomen), BACK PAIN (pain in their chest lower back), DISCOMFORT (middle of their body hurts), FLATULENCE (had a lot of gas), FEELING ABNORMAL (crappy feeling) and PAIN (The middle of their body hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported were levothyroxine Treatment details included Tylenol and Advil   Reporter did not allow further contact